Menu
Back to Archived Journals » Core Evidence » Volume 2
Core Evidence ceased publishing in January 2023. All articles that have been published in Core Evidence will continue to be available on the Dove Press site, and will be securely archived with CLOCKSS.
Core Evidence
ISSN: 1555-175X
- View all (143)
- Volume 15, 2020 (4)
- Volume 14, 2019 (6)
- Volume 13, 2018 (3)
- Volume 12, 2017 (2)
- Volume 11, 2016 (5)
- Volume 10, 2015 (9)
- Volume 9, 2014 (13)
- Volume 8, 2013 (7)
- Volume 7, 2012 (12)
- Volume 6, 2011 (7)
- Volume 5, 2010 (9)
- Volume 4, 2009 (20)
- Volume 3, 2008 (5)
- Volume 2, 2007 (22)
- Volume 1-Issues 3 & 4, 2006 (8)
- Volume 1-Issues 1 & 2, 2005 (11)
Archive: Volume 2, 2007
Original Research
Maraviroc: the evidence for its potential in the management of HIV
Louise Profit
Core Evidence 2007, 2:0-0
Published Date: 15 March 2007
Original Research
Bevacizumab: the evidence for its clinical potential in the treatment of nonsmall cell lung cancer
Sonya Haslam, Paul Chrisp
Core Evidence 2007, 2:0-0
Published Date: 15 March 2007
Original Research
Etanercept in psoriasis: the evidence of its therapeutic impact
Andrew Thomson
Core Evidence 2007, 2:0-0
Published Date: 15 March 2007
Original Research
Aprepitant: the evidence for its place in the prevention of chemotherapy-induced nausea and vomiting
Paul Chrisp
Core Evidence 2007, 2:0-0
Published Date: 15 March 2007
Original Research
Perindopril: the evidence of its therapeutic impact in hypertension
Andrew Thomson, Mary Greenacre
Core Evidence 2007, 2:0-0
Published Date: 15 March 2007